VIDEO: Post-stroke pioglitazone modestly protective against secondary vascular events

LOS ANGELES – Nondiabetic, insulin-resistant patients who started pioglitazone within 6 months of an ischemic stroke or transient ischemic attack had almost a 3% absolute risk reduction in secondary...
Source: Clinical Endocrinology News - Category: Endocrinology Source Type: news